PBM is one of the few strategies that simultaneously improves quality and drives fiscal stability. By optimizing patients’ blood health before major procedures and during all aspects of care delivery, PBM reduces avoidable complications and drives more successful recovery, allowing organizations to control cost and increase usable capacity.
Hospitals implementing PBM commonly achieve:
- ROI ranging from 120% to over 560%, with some mature programs achieving returns exceeding 700%
- Up to a 7:1 return on investment, including avoided downstream costs
- Shorter length of stay, freeing beds without capital expansion
- Improved surgical throughput, reducing cancellations and delays
- Reduced readmissions and improved resource utilization
- Revenue generation from the creation of new clinical services lines and evidence-based treatment delivery
PBM reduces high-cost resource use by decreasing reliance on blood components. For example, transfusing RBC units can cost over USD $1,200 each when including acquisition, processing, and labor. Activity-based platelet transfusion costs can average USD $1,360 per unit.
Most health systems report total savings of $2M–$10M annually, depending on patient volume and program maturity. Because PBM improves care while lowering cost, it functions as a margin-stabilizing strategy.
Disclaimer
The Society for the Advancement of Patient Blood Management (SABM) and the educational websites Iron Corner, Coag Corner, and Exec Corner do not provide medical advice. The content of these websites is intended for general informational purposes only and does not address individual circumstances. The information is not intended as a substitute for medical or legal advice, diagnosis or treatment, and its content should not be relied upon to make medical health decisions or for any other medical or legal purposes. Readers should never ignore medical advice in seeking treatment because of something they have read in the SABM website, Iron Corner, Coag Corner, or Exec Corner. Readers should make their own determinations as to: (i) what constitutes appropriate medical, technical, and administrative practices, and (ii) how best to evaluate and utilize for medical purposes any content posted in the SABM website, Iron Corner, Coag Corner, or Exec Corner educational resources and (iii) how best to comply with laws and regulations relevant to any questions. For the latter, readers should consider consulting, as to any medical matters, a qualified physician, and, as to any legal matters, an attorney familiar with related state and federal laws. The user of the SABM website, Iron Corner, Coag Corner, or Exec Corner, by accessing same, assumes all risks arising out of such use and releases SABM and its respective members, directors, officers and agents from and against any loss, damage, claim or liability arising out of such use of the SABM website, Iron Corner, Coag Corner, or Exec Corner. The SABM, Iron Corner, Coag Corner, and Exec Corner websites are based in the United States and the content herein as based on information (including, for instance, information and data pertaining to lab indices, pharmaceutical products and treatment protocols) pertaining to the United States for users in the United States. Additionally, information in this website pertaining to typical private and government insurance reimbursement issues may vary from one region of the United States to another. This site also contains “off label” information. Users of this website should be guided accordingly.